Clifford Swan Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.3M | Sell |
301,465
-8,028
| -3% | -$468K | 0.62% | 49 |
|
|
2025
Q4 | $16.7M | Sell |
309,493
-16,535
| -5% | -$795K | 0.55% | 50 |
|
|
2025
Q3 | $14.7M | Sell |
326,028
-21,972
| -6% | -$1.03M | 0.49% | 62 |
|
|
2025
Q2 | $16.1M | Sell |
348,000
-52,795
| -13% | -$2.59M | 0.57% | 51 |
|
|
2025
Q1 | $24.4M | Sell |
400,795
-26,243
| -6% | -$1.53M | 0.9% | 35 |
|
|
2024
Q4 | $24.2M | Sell |
427,038
-30,078
| -7% | -$1.68M | 0.87% | 34 |
|
|
2024
Q3 | $23.7M | Buy |
457,116
+51,537
| +13% | +$2.42M | 0.84% | 36 |
|
|
2024
Q2 | $16.8M | Sell |
405,579
-15,549
| -4% | -$696K | 0.63% | 51 |
|
|
2024
Q1 | $22.8M | Sell |
421,128
-2,696
| -0.6% | -$137K | 0.85% | 37 |
|
|
2023
Q4 | $21.7M | Sell |
423,824
-14,923
| -3% | -$783K | 0.85% | 36 |
|
|
2023
Q3 | $25.5M | Sell |
438,747
-2,251
| -0.5% | -$138K | 1.07% | 21 |
|
|
2023
Q2 | $28.2M | Sell |
440,998
-3,869
| -0.9% | -$259K | 1.14% | 18 |
|
|
2023
Q1 | $30.8M | Sell |
444,867
-2,615
| -0.6% | -$184K | 1.29% | 14 |
|
|
2022
Q4 | $32.2M | Sell |
447,482
-22,166
| -5% | -$1.67M | 1.4% | 13 |
|
|
2022
Q3 | $33.4M | Sell |
469,648
-25,275
| -5% | -$1.83M | 1.57% | 11 |
|
|
2022
Q2 | $38.1M | Sell |
494,923
-10,324
| -2% | -$786K | 1.65% | 11 |
|
|
2022
Q1 | $36.9M | Sell |
505,247
-20,242
| -4% | -$1.36M | 1.37% | 12 |
|
|
2021
Q4 | $32.8M | Buy |
525,489
+376
| +0.1% | +$22.1K | 1.15% | 22 |
|
|
2021
Q3 | $30.8M | Buy |
525,113
+4,030
| +0.8% | +$265K | 1.13% | 24 |
|
|
2021
Q2 | $35.7M | Buy |
521,083
+12
| +0% | +$782 | 1.35% | 15 |
|
|
2021
Q1 | $32.9M | Buy |
521,071
+854
| +0.2% | +$53.1K | 1.35% | 18 |
|
|
2020
Q4 | $32.3M | Sell |
520,217
-14,043
| -3% | -$864K | 1.41% | 15 |
|
|
2020
Q3 | $32.2M | Sell |
534,260
-118
| -0% | -$7.1K | 1.54% | 13 |
|
|
2020
Q2 | $31.4M | Sell |
534,378
-4,747
| -0.9% | -$284K | 1.62% | 12 |
|
|
2020
Q1 | $30.1M | Sell |
539,125
-1,655
| -0.3% | -$101K | 1.83% | 9 |
|
|
2019
Q4 | $34.7M | Buy |
540,780
+3,060
| +0.6% | +$175K | 1.68% | 10 |
|
|
2019
Q3 | $27.3M | Buy |
537,720
+13,474
| +3% | +$633K | 1.42% | 17 |
|
|
2019
Q2 | $23.8M | Buy |
524,246
+39,198
| +8% | +$1.83M | 1.25% | 24 |
|
|
2019
Q1 | $23.1M | Buy |
485,048
+28,855
| +6% | +$1.44M | 1.24% | 24 |
|
|
2018
Q4 | $23.7M | Buy |
456,193
+484
| +0.1% | +$26K | 1.44% | 18 |
|
|
2018
Q3 | $28.3M | Buy |
455,709
+9,232
| +2% | +$548K | 1.47% | 14 |
|
|
2018
Q2 | $24.7M | Buy |
446,477
+7,133
| +2% | +$385K | 1.38% | 15 |
|
|
2018
Q1 | $27.8M | Sell |
439,344
-6,216
| -1% | -$400K | 1.57% | 13 |
|
|
2017
Q4 | $27.3M | Buy |
445,560
+94,541
| +27% | +$5.91M | 1.49% | 12 |
|
|
2017
Q3 | $22.4M | Buy |
351,019
+14,345
| +4% | +$838K | 1.35% | 16 |
|
|
2017
Q2 | $18.8M | Buy |
336,674
+21,777
| +7% | +$1.19M | 1.17% | 23 |
|
|
2017
Q1 | $17.1M | Buy |
314,897
+91,490
| +41% | +$5.02M | 1.1% | 28 |
|
|
2016
Q4 | $13.1M | Buy |
223,407
+93,310
| +72% | +$5.1M | 0.87% | 35 |
|
|
2016
Q3 | $7.01M | Buy |
130,097
+32,613
| +33% | +$2.09M | 0.47% | 67 |
|
|
2016
Q2 | $7.17M | Sell |
97,484
-17,077
| -15% | -$1.21M | 0.5% | 67 |
|
|
2016
Q1 | $7.32M | Sell |
114,561
-13,947
| -11% | -$880K | 0.5% | 67 |
|
|
2015
Q4 | $8.84M | Sell |
128,508
-1,130
| -0.9% | -$74.7K | 0.61% | 60 |
|
|
2015
Q3 | $7.67M | Sell |
129,638
-3,174
| -2% | -$201K | 0.55% | 61 |
|
|
2015
Q2 | $8.84M | Sell |
132,812
-3,957
| -3% | -$261K | 0.59% | 57 |
|
|
2015
Q1 | $8.82M | Sell |
136,769
-364
| -0.3% | -$22.8K | 0.58% | 56 |
|
|
2014
Q4 | $8.1M | Sell |
137,133
-981
| -0.7% | -$55.3K | 0.53% | 55 |
|
|
2014
Q3 | $7.07M | Buy |
138,114
+185
| +0.1% | +$9.24K | 0.48% | 63 |
|
|
2014
Q2 | $6.69M | Sell |
137,929
-5,349
| -4% | -$264K | 0.45% | 63 |
|
|
2014
Q1 | $7.44M | Buy |
143,278
+7,071
| +5% | +$376K | 0.52% | 56 |
|
|
2013
Q4 | $7.24M | Sell |
136,207
-3,590
| -3% | -$183K | 0.52% | 56 |
|
|
2013
Q3 | $6.47M | Sell |
139,797
-2,550
| -2% | -$112K | 0.52% | 57 |
|
|
2013
Q2 | $6.36M | Buy |
+142,347
| New | +$6.18M | 0.53% | 56 |
|
Other funds holding BMY
VCM
VPM
Clifford Swan Investment Counsel's BMY Position: Q1 2026 in Review
Clifford Swan Investment Counsel reduced its Bristol-Myers Squibb (BMY) stake by 2.6% in Q1 2026, selling an estimated $468K and leaving 301,465 shares worth $18.3M. The position accounts for 0.62% of the portfolio, ranked #49.
Clifford Swan Investment Counsel first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.1M in Q2 2022. 2,527 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Clifford Swan Investment Counsel held 301,465 shares of Bristol-Myers Squibb worth $18.3M as of Q1 2026.
- Clifford Swan Investment Counsel sold 8,028 Bristol-Myers Squibb shares in Q1 2026, an estimated $468K.
- Bristol-Myers Squibb made up 0.62% of Clifford Swan Investment Counsel's portfolio in Q1 2026, its #49 holding.
- Clifford Swan Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Clifford Swan Investment Counsel's Bristol-Myers Squibb position peaked at $38.1M in Q2 2022.
- 2,527 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Clifford Swan Investment Counsel's 13F filing for Q1 2026, filed 6 May 2026.